The impact of prophylactic ureteral stenting during kidney transplantation on postoperative surgical outcomes

다국어 초록 (Multilingual Abstract)

Background: The aim of this study was to evaluate the safety and feasibility of prophylactic ureteric stenting during kidney transplantation (KT).
Methods: The authors retrospectively reviewed patients who underwent KT between June 2016 and June 2019. The prophylactic ureteral stenting group (double-J [DJ]) and no-stent group (no-DJ) were compared with respect to the clinical data and surgical outcomes.
Results: A total of 42 patients underwent KT; 17 patients were classified into the DJ group and 25 patients into the no-DJ group. Antithymocyte globulin induction and donor- specific antibody positivity were significantly higher in the DJ group. There were no significant differences between the groups in terms of symptomatic urinary tract infection (UTI). The time to postoperative UTI was significantly shorter in the DJ group than in the no-DJ group (33.5±7.8 vs. 105.3±71.6 days, P=0.013). The development of postoperative BK viremia was significantly higher in the no-DJ group (0.0% vs. 16.0%, P=0.035). Urologic complications were significantly higher in the no-DJ group (0.0% vs.
16.0%, P=0.035). In the no-DJ group, urologic complications occurred in four patients: ureteroneocystostomy stenosis in three patients and ureteroneocystostomy leakage in one patient. Percutaneous ureteral interventions were performed for all patients using percutaneous nephrostomy and reno-uretero-vesical stenting. However, there were no postoperative urologic complications in the DJ group.
Conclusions: Prophylactic ureteric stenting during KT may be safe and feasible without significantly increasing the incidence of UTI and BK viremia. Additionally, prophylactic ureteric stenting may reduce urologic complications after KT

참고문헌 (Reference)

1 Butterworth PC, "Urological complications in renal transplantation : impact of a change of technique" 79 : 499-502, 1997

2 Junjie M, "Urological complications and effects of double-J catheter in ureterovesical anastomosis after cadaveric kidney transplantation" 30 : 3013-3014, 1998

3 Goldman JD, "Urinary tract infections in solid organ transplant recipients : Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice" 33 : e13507-, 2019

4 Fayek SA, "Ureteral stents are associated with reduced risk of ureteral complications after kidney transplantation : a large single center experience" 93 : 304-308, 2012

5 Thomas A, "Ureteral stents : a novel risk factor for polyomavirus nephropathy" 84 : 433-436, 2007

6 Hashim F, "Ureteral stent placement increases the risk for developing BK viremia after kidney transplantation" 2014 : 459747-, 2014

7 Kayler L, "Ureteral stent placement and BK viremia in kidney transplant recipients" 15 : 202-207, 2013

8 Wingate JT, "Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation" 19 : e12644-, 2017

9 Karam G, "Ureteral necrosis after kidney transplantation : risk factors and impact on graft and patient survival" 78 : 725-729, 2004

10 Visser IJ, "Timing of ureteric stent removal and occurrence of urological complications after kidney transplantation : a systematic review and meta-analysis" 8 : 689-, 2019

11 Lumiaho J, "The morphological, in situ effects of a self-reinforced bioabsorbable polylactide (SRPLA 96) ureteric stent: an experimental study" 164 : 1360-1363, 2000

12 Mannu GS, "The ideal timing of ureteric stent removal in transplantation patients" 27 : e96-e97, 2014

13 Haas M, "The Banff 2017 Kidney Meeting Report:revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials" 18 : 293-307, 2018

14 Mangus RS, "Stented versus nonstented extravesical ureteroneocystostomy in renal transplantation : a metaanalysis" 4 : 1889-1896, 2004

15 Kumar A, "Significance of routine JJ stenting in living related renal transplantation : a prospective randomised study" 30 : 2995-2997, 1998

16 Abrol N, "Routine stenting of extravesical ureteroneocystostomy in kidney transplantation : a systematic review and meta-analysis" 50 : 3397-3404, 2018

17 Wilson CH, "Routine intraoperative stenting for renal transplant recipients" 80 : 877-882, 2005

18 Patel P, "Prophylactic ureteric stents in renal transplant recipients : a multicenter randomized controlled trial of early versus late removal" 17 : 2129-2138, 2017

19 Atencio IA, "Polyomavirus replicates in differentiating but not in proliferating tubules of adult mouse polycystic kidneys" 201 : 26-35, 1994

20 Yuksel Y, "Optimal timing for removal of the double-J stent after kidney transplantation" 49 : 523-527, 2017

21 Alangaden GJ, "Infectious complications after kidney transplantation : current epidemiology and associated risk factors" 20 : 401-409, 2006

22 Tavakoli A, "Impact of stents on urological complications and health care expenditure in renal transplant recipients: results of a prospective, randomized clinical trial" 177 : 2260-2264, 2007

23 Kumar A, "Evaluation of the urological complications of living related renal transplantation at a single center during the last 10 years : impact of the Double-J stent" 164 (164): 657-660, 2000

24 Cormio L, "Biocompatibility of various indwelling double-J stents" 153 : 494-496, 1995

25 Atencio IA, "Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration" 67 : 1424-1432, 1993